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ABSTRACT
ONTOGENY OF THE FETAL IMMUNE RESPONSE TO MATERNAL SMOKING IN
RELATION TO ALLERGIC ASTHMA
By
James B. Kopiich
The relationship between maternal smoking and the prenatal origins of allergic disease 
was studied in 78 unselected mothers and their corresponding newborns with a sensitive 
test for interleukin-4 (IL-4), interferon-y (IFN-y), and cotinine as a biological marker to 
validate smoking data. For both maternal [F(3, 74) = 26.43, g  < .0001] and cord blood 
cotinine [F(3, 74) = 25.2, p < .0001] significantly higher levels were observed for 
smokers compared to non-smokers in a dose-response pattern and a high correlation was 
found between maternal and cord blood cotinine serum, r  = .87, g  < .0001, indicating a 
good method to confirm the presence of maternal smoking. No association was observed 
between cord blood IL-4 and maternal smoking, maternal serum cotinine, or cord blood 
cotinine, respectively. An association was observed between maternal IL-4 and cord 
blood IL-4, r = .37, g  < .01, suggesting a maternal-fetal cytokine interaction. Newborn 
birth weight significantly decreased as a function of daily maternal smoking, and 
maternal and cord blood cotinine, in a dose-response manner. Data on maternal smoking 
effects on selected perinatal variables are reported. Discussion of the pertinence of 
additional studies required to elucidate mechanisms involved in prenatal sensitization in 
relation to maternal smoking are discussed.
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Introduction
Trends in the development and severity of allergic disease are increasing at an 
alarming rate resulting in overwhelming public concern on a global scale. In particular, 
we have wimessed soaring prevalence rates of asthma and allergy in children within the 
past two decades (Burr, Butland, King, and Vaughn-Williams, 1989; Haahtela, Lindholm, 
Bjorksten, Koskenvuo, and Laitinen, 1990; Hsieh & Shen, 1988; Robertson, Heycock, 
Bishop, Nolan, Olinsky, and Phelan, 1991; Shaw, Crane, O’Donnel, Porteous, and 
Coleman, 1990). Effective control of allergic disease is still elusive partly due to the 
paucity of knowledge in the underlying pathogenic mechanisms.
Sensitization is the most critical event in the development of allergic disease. At 
least four separate components can be identified as being responsible for the development 
of sensitization to environmental antigens; genetic susceptibility, dose, timing, and 
duration of exposure. Genetic susceptibility can be explained as the predisposition for 
generating inappropriate amounts of immunoglobulin E antibody (IgE) against common 
environmental allergens, expressed clinically as asthma, eczema, and liiino- 
conjunctivitis. This predisposition is referred to as ‘atopy’. Dose and duration are 
involved with the ability of the immune system to become sensitized to the allergen in 
question. At critical doses, less duration would be required for sensitization to occur and 
vice versa. This relationship of course would be a function of the degree of genetic 
susceptibility expressed by the individual, lending evidence to a dynamic interplay of 
factors in the development of sensitization. Timing has recently proven to be an 
important variable in this context. It has become increasingly apparent that the first 12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
months of life are more likely to induce IgE-mediated hypersensitivity than antigens 
encountered later (Arshad & Hide, 1992).
Of particular interest are allergens derived from domestic dust mites, proteins 
from domestic pets, cockroaches, fungal antigens and pollens (Holgate, 1997). In 
addition, environmental tobacco smoke and maternal smoking has been shown to 
contribute to the onset and exacerbation of allergic disease (Jedrychowski & Flak, 1997; 
Martinez, Cline and Burrows, 1992).
The sensitization mechanism is initiated by the participation of cells, which 
recognize, process, and, in turn present allergens to the T (thymus)-cell effector arm of 
the immune system. Antigen presenting cells (APCs) including dendritic cells and 
activated B-(bursal) cells and more commonly, although not as effective, macrophages, 
act to engulf antigen, initiating a cascade of membrane and intracellular events involving 
interactions with MHC (major histocompatiblity complex) class 11 molecules, ultimately 
ending in the surface expression of small peptide fragments (epitopes) coding for 
appropriate T-cell activity. With respect to allergic disease, the allergen tends to code for 
the CD4+ (cluster of differentiation) T helper (Th) cell population.
T helper cells possess a functional heterogeneity about them, including cytokine 
secretion and expression of various surface receptors and can, thus, be divided into 
subpopulations. The generation of interferon-gamma (IFN-y), tumor necrosis factor-beta 
(TNF-P), and interleukin-2 (lL-2) are unique to Thl cells, whereas Th2 cells produce 
predominately interleukin(s) -4, -5, -6, -10, and -13 (Mosmann, Cherwinski, Bond, Geidi, 
and Coffman, 1986; Mosmann & Coffinan, 1989). These effector cells develop from the 
T helper progenitor (Thp) cells, which differentiate as a result of the microenvironment’s
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
influence via signals delivered by secreted cytokines and co-stimulatory molecules. 
Factors responsible for the direction of differentiation at the Thp stage include; IFN-y, 
promoting Thl cell production, both in vitro (Gajewski et al., 1989; as cited in Maggi, 
PaiTonchi, Manetti, Simonelli, Piccinni, Rugio, Carli, Ricci and Romagnani, 1992) and in 
the Leishmania model in vivo (Locksley, 1991; as cited in Maggi et al., 1992). 
Reciprocally, lL-4 induces Th2 production, again both in vitro (Demeure, Yang, Byun, 
Ishihara, Vezzio, and Delespesse, 1995) and in vivo (Coffman, 1991; as cited in Maggi et 
al., 1992). Thl and Th2 subsets are hypothesized to cross regulate phenotypic expression 
of each other.
In a recent in vivo study, infection with Bacillus Calmette-Guérin (BCG) resulted 
in Thl responding, and subsequent aeroallergen challenge being met with an attenuated 
response (Erb, Holloway, Sobeck, Moll, and Le Gros, 1998). Conversely, IL-10 
production by the Th2 subset attenuated the effects of IFN-y (D’Andrea. Aste-Amezaga, 
Valiante, Ma, Kubin, and Trinchieri, 1993). Further evidence has addressed this issue 
following a review of epidemiological studies assessing the global incidence of allergic 
disease in children (Doull & Holgate, 1997). It was found that children of increasing 
birth order and those from third world countries had lower prevalence rates of developing 
allergic disease. The hypothesis presented to account for this seemingly idiosyncratic 
response was that exposure to viral inflections in early life occurs more often in these 
populations, offering protection against allergy evolvement. Thus, reactive Thl 
responding to infection prevents sensitization to provoking allergens by sufficiently 
suppressing Th2 participation.
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In focusing on the role of Th2 responding, it is important to review the utility of 
relevant cytokines. IL-4 has proven to be the most influential cytokine in the induction of 
IgE synthesis in reaction to allergen/APC influence on T-cells. IgE synthesis takes place 
after virgin B-cells arrive at a secondary lymphoid organ, where they undergo antigen- 
dependant selection. Once mature, the B-cells can become memory cells or be prodded 
by IL-4 to mature into plasma cells. These plasma cells, in the presence of IL-4, will 
undergo a unique iso-type class switch from production of immunoglobulin M (IgM) to 
IgE. Antibodies of the IgE class have a central role in allergic disease, with elevated 
levels of both total and allergen-specific IgE in serum of atopic patients (Barbee, 
Halonen, Kaltenbom, and Burrows, 1991). IL-5 (Pêne, Rousset, Brière, Chrétien, 
Wideman, Bomiefy and de Vries, 1988) and IL-6 (Vercelli, Jabara, Arai, Yokota, and 
Geha, 1989) have been demonstrated to play an obligatory role in the IL-4 dependent 
induction of IgE. In addition, asthma inspired CD4+ T-lymphocyte activation is 
accompanied by increased serum concentrations of IL-5 (Corrigan, Hamid, North, 
Barkans, Moqbel, Durham, Gemou-Engesaeth and Kay, 1993). IL-10 appears to act 
antagonistically to IFN-y, which is responsible for attenuation of IL-4 induced IgE 
synthesis (D’Andrea et al., 1993), thus furthering the actions of Th2 effector cells.
IgE antibodies, coded for the antigen which began this myriad of immune events, 
attach themselves to surface receptors on mast cells. This process can last weeks and 
even months in anticipation of the second encounter with allergen. This ‘priming’ 
mechanism is the basis of sensitization, and interestingly, results in no overt 
symptomatology. Bi later encounters between the allergen and the body, allergen 
molecules promptly bind to IgE antibodies on mast cells. When one such molecule
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
connects with two IgE molecules in a bridge-like fashion, it draws together the attached 
IgE receptors, and the mast cell springs to life. Activation involves cascades of 
enzymatic reactions resulting in calcium-mediated expulsion of chemical-laden granules 
(Bissonnette & Befus, 1998). Various chemicals released by mast cells are accountable 
for expressed allergic symptoms.
Tissue damage occurs later as fiequency of allergen exposure is maintained. Of 
considerable concern is the recruitment of eosinophils to the tissue area (Desreumaux & 
Capron, 1996; Gleich, 1996) by which IL-5 plays a central role (Egan, Umland, Cuss, 
and Chapman, 1996). Proteins secreted from these cells, including major basic protein 
(MBP) and eosinophil cationic protein (ECP), appear to be detrimental to epithelial 
integrity, thus contributing significantly to airway pathology exhibited by asthmatics. 
Evidence of this process includes correlations of eosinophil numbers and the 
pathogenesis of allergic disease (Walker, Kaegi, Braun, and Blaser, 1991).
Smoking has been shown to promote Th2 activity in the immune system. Sherill, 
Halonen, and Burrows (1994) reported on a twenty-year follow-up analysis describing 
the relationships between IgE levels, atopy and smoking. The findings revealed that 
smoking and atopy were both related to significant elevations in total serum IgE, in a 
dose-response fashion, suggestive of a causal association. Zetterstrom, Vega, Huyghe 
and Zurwaski (1981) examined the risks of smoking and occupational allergy. They 
found that IgE was increased in smokers concomitant with sensitization against 
occupational allergens. These data were further supported by Taylor, Gross, Joyce, 
Holland, and Pride (1985) where IgE was greater in smokers and ex-smokers versus non- 
smokers. In addition, they reported smokers displaying higher eosinophil counts. Byron,
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Varigos, and Wooton (1994) demonstrated that phytohaemaglutinin (PHA)-induced IL-4 
production by peripheral blood mononuclear cells (PBMCs) was significantly higher in 
smokers as compared to non-smokers. In a study questioning the effect of passive 
smoking on children, it was found that children of smoking parents had a higher 
incidence of respiratory illnesses per year, significantly higher total leukocytic and 
eosinophil counts, higher percentage of eosinophils and increased concentrations of 
serum IL-4 and IgE in a dose-response manner to parental smoking (el-Nawawy, 
Soliman, el-Azzouni, Amer, Demi an, and el-Sayed, 1996). Given the evidence from 
smokers and their children, increased IL-4 production may be part of the mechanism 
responsible for the above increases in serum IgE and allergic-like symptoms associated 
with cigarette smoking.
Prenatal Origins
Recently it has been suggested that sensitization to allergens may occur as early 
as in utero. Following T-cell development during gestation, the first lymphocytes are 
detectable in the thymus at eight to nine weeks of pregnancy. It has been shown that the 
more mature T-cells can demonstrate proliferative responses at this time (Toivanen, 
Uksila, Leino, Lassila, Hirvonen, and Ruuskanen, 1981). More notably, T-cells migrate 
into fetal circulation at about 15-16 weeks of gestation. Warner (1997) reported 
proliferative responses to PHA in PBMCs starting at 17 weeks, which continued to 
increase, being significantly higher in the second and third trimester. Furthermore, a 
similar increase in proliferative responses to specific inhalant and ingestant allergens has 
been determined (Jones, Miles, Warner, Colwell, Bryant and Warner, 1996), supporting 
the theory of prenatal programming.
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Prenatal programming is supported further by positive proliferative responses of 
fetal T-cells to a range of allergen sources including, house dust mite, cat fur, birch tree 
pollen, p iactoglubulin, and ovalbumin from as early as the 22“** week of gestation 
(Warner, 1997). These data effectively support that maternal exposure to allergens is 
sufficient in priming of fetal T-cells such that, when confronted with environmental 
allergens antenatal, responding becomes consequential.
A growing body of research suggests that maternal tobacco smoking is associated 
with decreased lung development and function in offspring. For example, Taylor & 
Wadsworth (1987) conducted a national study in the United Kingdom on 12, 743 children 
and confirmed that maternal smoking had a significant influence on the reported 
incidence of bronchitis and admission to hospital for lower respiratory tract infections 
(LRTIs) during the first five years of life. In Sweden, Carlsen, Jaakkola, Nafstad, and 
Carlsen (1997) assessed a birth cohort of 3, 754 newborns for breathing parameters and 
respiratory mechanics. They found that maternal smoking affected tidal breathing 
parameters in newborns, and the decline in lung function was directly proportional to the 
number of cigarettes smoked per day by the mother. Chen, Kimizuka, and Wang (1987) 
in Quebec, Canada, studied lungs from fetuses (postmortem) of smoking mothers 
compared to those of nonsmoking mothers and showed that there were significant 
differences between the groups morphologically. To compare lung function between 
infants of smoking mothers to infants with a family history of asthma. Sheikh, Goldsmith, 
Howell, Parry, and Eid (1999) conducted a cross-sectional study. Findings included 
evidence that the infants showed no statistically significant difference on a variety of 
respiratory measures, however in response to bronchodilators the asthmatic history group
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responded positively. Jedrychowski & Flak (1997) studied a sample of 1,129 grade two 
students from Poland and found that the relative risk of developing respiratory infection 
became significant after prenatal exposure to smoking was included in addition to 
posmatal environmental tobacco smoke (ETS). Martinez et al. (1992) from Arizona, 
USA, revealed that in a group of 786 children, those who where exposed to maternal 
tobacco smoke in utero (10+ cigs/day) were 2.5 times more likely to develop asthma and 
had a 15.7% lower maximal midexpiratory flow. In an epidemiological study assessing 
whether reported deficits in lung function in newborns persist in later childhood, it was 
found that maternal smoking and/or ETS exposure in the first few years of life was 
attributable to sustained altered pulmonary function throughout the child’s life 
(Cunningham, Dockery, Gold, and Speizer, 1994). Arshad & Hide (1992) followed a 
group of 1,167 infants for 1 year in a population-based prospective study to assess the 
effect of environmental factors on the development of allergic disorders. They found that 
maternal smoking produced odds ratio of 2.30 (p < 0.003) as being a risk factor for the 
development of asthma. In a similar study by Infante-Rivard, Gautrin, Malo and Suissa 
(1999) a group of 457 children were followed in Montreal, Canada after meeting 
experimental criteria, most notably to have been diagnosed for the first time with asthma 
at an emergency room at the designated hospital. The findings included maternal 
smoking as a risk factor for childhood asthma. In particular smoking less than 20 
cigarettes per day produced an odds ratio of 1.22 and maternal smoking of greater than 20 
produced an overwhelming odds ratio of 3.84.
Taken together, these studies indicate that maternal smoking has the potential to 
alter lung development and increase susceptibility to LRTIs and/or asthma thereafter. It
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has been hypothesized that the increase in prevalence rates of childhood asthma may be 
partially due to increased prevalence of smoking among women of childbearing age 
(Martinez, 1997). With respect to Canada, the prevalence of female smokers of 
childbearing age (20-44) is 34%. Ontario was estimated at 33% and Thunder Bay, 
Ontario was reported at 44% (Ontario Health Survey, 1990). These statistics make 
Thunder Bay an excellent candidate for research in this growing field.
Less attention has been directed towards elucidating the process by which 
maternal smoking leads to increased potential for respiratory complications in offspring. 
Magnusson (1986) reported increased levels of IgE in umbilical cord blood of smoking 
mothers after controlling for parental allergic history. Contrary to these findings, Ownby, 
Johnson and Peterson (1991) and Oryszczyn, Godin, Annesi, Hellier, and Kauffinan 
(1991) both found that, after increasing the sample size and controlling for several more 
confounding variables, IgE in cord blood was not affected by maternal smoking. 
Neutrophils are shown to be decreased in cord blood of smoking mothers (Mercelina- 
Roumans, Breakers, Ubachs, and van Wersch, 1996; Harrison, 1979), as well, IgG and 
IgA are elevated in cord blood (Cederqvist, Eddey, Nagwa, and Li win, 1984), suggesting 
an explanation for the enhanced incidence of postnatal infection seen in children of 
smoking mothers. What has yet to be investigated is fetal cytokine production in cord 
blood of smoking mothers. One possible explanation for the disparate IgE findings is 
that the child is not yet producing IgE since the child has not yet been exposed to ETS or 
the allergen directly. However, the fetal immune system may have been primed, in utero, 
by excessive Th2 responding by the smoking mother. Such priming could influence fetal
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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immune functioning in the Th2 direction, so that when exposed to ETS antenatally, rapid 
responding ensues, leading to IgE-mediated sensitization.
The focus of this study is to examine tobacco smoking effects on immune 
functioning in relation to allergic asthma by comparing maternal and cord blood samples 
of smoking and non-smoking mothers. Consequently, a comparison of perinatal 
variables between these groups is also intended. Particularly, the fetal immune response 
and perinatal outcome to intrauterine tobacco exposure via maternal smoking deserves to 
be investigated.
Sensitization is critical when considering what might be responsible for smoker’s 
childrens’ greater susceptibility to asthma. As explained earlier, any allergic disease 
becomes phenotypic only after sensitization occurs. The question then arises, what 
mechanisms are in place to allow or prevent sensitization from occurring? The above 
discussion clarifies the important role T-cells and cytokines play in orchestrating the 
asthmatic or allergic response and most notably the role of IL-4 and IFN-y. Researchers 
agree that excessive Th2 responding is primarily responsible for initiating IgE synthesis 
and subsequent mast cell sensitization to allergens. One could envisage an immune 
system favouring Th2 and deficient in T h l responding, which would be conducive to 
sensitization, just as, conversely, exposure to infections in third world countries has been 
speculated to be protective since it encourages Thl responding.
Despite the intimate contact between fetal-derived allogenic tissue and maternal- 
derived decidual tissue, generally the immunocompetent mother does not reject the fetus. 
Several mechanisms have been proposed, which create an intrauterine milieu propitious 
to the continuation of pregnancy. The regulatory role cytokines play to this avail has
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been recently elucidated. Successful pregnancy has been shown to be associated with a 
skew in T-cell operation towards Th2 expression (Wegmann, Lin, Guilbert and 
Mossmann, 1993). This shift in T-cell population of the fetoplacental unit to produce 
Th2 cytokines inhibits maternal T h l cytokine production. Thus, whether the mother is 
allergic or not, the fetus is exposed to conditions that would favour the development of 
Th2-like responses (Warner, Jones, Jones, and Warner, 2000). It is believed that, towards 
the end of gestation, IFN-y (Thl) levels elevate to guard against fetal allergic 
sensitization. However, the interaction between pregnancy and smoking may inhibit this 
mechanism due to excessive Th2 suppression of IFN-y. Supporting this argument is 
evidence of low IFN-y levels in cord blood being predictive of atopic eczema (Warner, 
Miles, Jones, Quint, Colwell and Warner, 1994). Hence, it would appear probable that 
interactions between Thl and Th2 cytokines during pregnancy are influential in 
determining the type of immune response that develops in utero and carries on into early 
life. Taken together, pregnancy already coupled with Th2 activity with the addition of 
further Th2 responding from maternal smoking, may partially be responsible for 
sensitization or securing a Th2 immuno-environment at birth.
Maternal smoking is hypothesized to play an integral role in influencing the fetal 
immune system at critical periods of immuno-development. Because of the degree of 
Th2 responding to smoking and the susceptibility of the naïve fetal immune system, fetal 
T-cell repertoires may be significantly shifted in the Th2 direction, away from T hl. A 
cord blood measure of IL-4 would verify this assumption and a measure of IFN-y would 
verify a deficiency of T hl activity.
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12
The proposed study attempts to provide evidence of intrauterine priming of Th2 
expression resulting from maternal smoking in relation to allergic asthma.




Participants were recruited in Thunder Bay, Ontario, Canada, from prenatal 
clinics and classes. To be eligible mothers must have planned to deliver at Thunder Bay 
Regional Hospital within the testing window, be expecting a live singleton fetus and have 
completed a questionnaire and provided informed consent (Appendix A).
In total, 99 mothers were recruited from the above-mentioned sources. Within the 
total, 21 participants were excluded from the analysis; 10 were missed for reasons of the 
investigator not being called to the delivery; 4 did not provide viable blood samples 
(hemolyzed or lack of volume); and 7 delivered after the study was completed. Thus, 
included in the study were 78 mothers and their respective newborns.
Test Materials and Procedure
Questionnaire. Development of the “Lifestyles in Pregnancy” questionnaire (Appendix 
B) was intended to assess a select group of variables, with respect to maternal lifestyles 
during pregnancy, and to explore how these variables influence chosen immune system 
parameters. Special attention was given to maternal smoking rates in comparison to 
maternal non-smoking.
Dissemination of research results was provided via participants filling out the 
“request for results” form (Appendix C).
Delivery and Postpartum Data Collection o f Perinatal Variables. Information was 
collected surrounding the time of each delivery including the duration of gestation, birth 
order of the newborn (parity), APGAR scores taken at 1 and 5 minutes of life, newborn
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weight, method o f delivery, presence or absence of gestational diabetes, and the presence 
or absence of meconium stain. Collectively these data are referred to as ‘perinatal 
variables’.
Sample Collection and Analyses. Upon admission to the hospital for delivery, 
participants having routine admission blood work performed had an additional 10 ml tube 
drawn for the purpose of this study. Once the fetus had been delivered umbilical cord 
blood was collected by following this protocol when possible; the clamped cord attached 
to placenta was washed using saline solution intending to clean away maternal blood; the 
cord was undamped and allowed to drain into a sterile cup by elevating the attached 
placenta; cord blood was then collected by pouring into serum separator tubes. The 
removal of cord blood and pouring into tubes technique was developed in order to 
eliminate the possibility of hemolysis caused by use of a syringe, and to ensure purity of 
the samples, washing was performed.
Blood samples were allowed to sit for 30 minutes after collection to allow clotting 
followed by centrifugation to separate the serum. Serum was aliquoted into 4 tubes, 
marked and frozen at -20 “ C until assay was performed.
Maternal contamination of the umbilical cord blood is certainly a confounding 
variable. This issue was dealt with by screening the cord blood for the presence of 
immunoglobulin-A (IgA) (Piastra, Stabile, Fioravanti, Castagnola, Pani, and Ria, 1994). 
IgA does not cross the placental barrier and is elevated in the pregnant mother, thus its 
existence in cord blood would be a marker of maternal contamination. Each cord sample 
collected fell below the sensitivity of the IgA assay employed (<0.07 g/L). The IgA 
reference range for an adult is 0.639-3.82 g/L.
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Total IL-4 and IFN-y was quantified by employing a sandwich enzyme 
immunoassay technique (ELISA), using a commercial immunoassay (R&D Systems, 
Minn, USA.). Only 60 of the 78 participant’s blood and corresponding cord blood 
samples were selected to be subjected to the ELISA. The selection was based on 
choosing the 30 highest smokers and 30 non-smokers. Standards and serum samples 
were added individually in duplicate to microplate wells coated with a monoclonal 
antibody specific for IL-4 or IFN-y cytokines. The immobilized antibody would bind any 
cytokine present. After washing away any unbound substances, an enzyme-linked 
polyclonal antibody speciEc for the cytokine was added to the wells. Following a wash 
to remove any unbound antibody-enzyme reagent, a substrate solution was added to 
induce a colour reaction in proportion to the amount of cytokine bound in the initial step. 
A stop solution was applied at a specific time and the intensity of the colour was 
measured using an ELISA plate reader. Techniques for the assay precisely followed 
those provided for in the kits. Controls were assayed in duplicate by the investigator to 
ensure the reliability of the ELISA’s and consistency of techniques. The sensitivity of 
the standard ELISA’s used ranged from 31.2 pg/ml to 2000 pg/ml for the IL-4 assay and 
from 15.6 pg/ml to 1000 pg/ml for the IFN-y assay. High sensitivity IL-4 ELISA was 
performed producing results sensitive from 0.25 pg/ml to 16 pg/ml.
Calculation of the results were obtained by creating a standard curve and plotting 
the mean absorbance for each standard on the y-axis against the concentration on the x- 
axis and drawing a best fit curve through the points on the graph.
To assess the validity of self-reported smoking histories from the mothers, 
cotinine was measured in both maternal and cord samples by using a commercial
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immunoassay (Serex Inc., New Jersey, USA) validated for the semi-quantification of 
cotinine in human saliva and urine. The immunoassay was validated for use with human 
serum by the investigator by means of spiking negative serum samples with known levels 
of cotinine to create a standard curve for which to compare unknowns. The sensitivity of 
the assay ranged from 8 to 250 ng/ml. In addition, this information was used to assess 
placental transfer of cotinine and to explore relationships between cotinine levels and the 
selected perinatal variables. Of the major metabolites of nicotine, cotinine is a suitable 
candidate for a marker of smoking as it has a relatively long half-life of 10-40hrs and is a 
proven marker of maternal smoking (Oryszczy n et al., 1991; Ownby et al., 1991; 
Mochizuki, Maruo, and Masuko, 1984).
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Results
Descriptive characteristics of the participants are presented in Table 1 (page 44).
Both IL-4 and IFN-y were undetectable in both maternal and cord blood using the 
standard ELISA kit sensitive to 31.2 and 15.6 pg/ml respectively. A high sensitivity IL-4 
ELISA (sensitivity range: 0.25 — 16 pg/ml) was performed on a subset of 59 matched 
matemal/cord blood samples able to detect presence of cytokine. No significant 
difference in IL-4 levels was found between smoking and non-smoking groups in both 
maternal and cord blood samples. ANOVA methods designed to test differences between 
non-smoking, light smoking (1-8 cigarettes/day), moderate smoking (9-15) and heavy 
smoking (>15) as a function of IL-4 levels produced no significant Endings for both 
maternal and cord blood samples. No association was observed between maternal 
allergic and asthmatic history and maternal and cord blood IL-4. Maternal and cord 
blood cotinine levels were separated into 7 groups (0, 8, 16, 31, 62, 125, and 250 ng/ml) 
to search for differences as a function of IL-4 concentration. No main effect was found 
in either maternal or cord blood cotinine groups. Contrasts evaluation revealed 
significant differences between grouping lower cotinine concentrations (8, 16, and 31 
ng/ml) against higher (62, 125 and 250 ng/ml) in maternal blood samples, t(18.84) = 
2.82, 2  < .011. Parallel analysis for cord blood approached significance, t(5.67) = 2.47, p 
< .051. Correlational analysis presented a positive relationship between maternal and 
cord blood IL-4 concentrations, r = .37, p < .004 (Figure 1).
Maternal smoking was separated into subgroups as a function of cigarettes 
smoked per day: non-smoker = 0, light smoker = 1-8, moderate = 9-15, and heavy = > 15 
for ANOVA. Maternal cotinine concentrations were found to increase with matemal
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smoking, F(3, 74) = 26.43, p < .0001. The concentration o f cord blood cotinine was 
found to increase with the degree of matemal smoking, F(3, 74) = 25.20, p < .0001. 
Daily caffeine consumption by the mother increased with the degree of matemal 
smoking, F(3, 74) = 11.43, p  < .0001. Newbom birth weight followed a downward trend 
as matemal smoking, matemal cotinine and cord blood cotinine increased (Figure 2),
F(3, 74) = 4.36, p  < .007; F(6, 71) = 3.33, p  < .006; and F(6, 71), p  < .017 respectively. 
No significant findings were revealed to indicate a relationship between the degree of 
matemal smoking and newbom APGAR scores ( l o r  5 min.) as a function of matemal 
cotinine, cord blood cotinine or reported daily matemal smoking habits.
The cotinine assay employed allowed for the discrimination between 7 
concentrations measured in ng/ml; 0, 8, 16, 31, 62, 125 and 250. These concentrations 
were used in ANOVA for the following results. The concentration of matemal serum 
cotinine increased with the number of cigarettes smoked per day, F(6, 71) = 25.21, p  < 
.0001, creating a dose-response relationship (Figure 3). Matemal weekly exercise is 
associated with increasing matemal cotinine, with the highest frequency taking place in 
the highest concentration and the lowest frequency in the zero level, F(6, 71) = 25.21, p  < 
.013. Simple effects reveal that the differences largely lie between grouping the lower (8, 
16, and 31ng/ml) against the higher (62, 125, and 250ng/ml) cotinine groups, t(3.73) = 
4.66, p  < .015. Differences in average daily caffeine consumption by the mother was 
found to produce differences in the concentrations o f matemal serum cotinine, F(6, 71) = 
2.95, p  < .013. Further analysis on this variable via contrasts revealed that the differences 
largely lie between zero level serum cotinine and 62ng/ml, 125ng/ml, and 250ng/ml 
respectively, at t(3.24) = 12.61, p  < .007; t(4.79) = 13.14, p  < .0001, and t(3.90) = 7.11, p
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< 0.006. Matemal age of the smoking and non-smoking groups were significantly 
different, t(76) = 2.08, p < .05.
Cord blood cotinine levels were found to be significantly associated with matemal 
cotinine in a dose response fashion, r  = .865, p  < .0001 and have significant differences 
between concentration groups, F(6, 71) = 21.64, p  < .0001 (Figure 4). Matemal 
cigarettes smoked per day indicates an increase in cord blood cotinine, r  = 0.66, p  < 
.0001, and a difference between cotinine groups, F(6, 71) = 21.64, p  < .0001. Matemal 
daily caffeine consumption is associated with an increase in cord blood cotinine, F(6, 71) 
= 4.3, p < . 001.
Table 2 (page 46) summarizes significant correlations (Pearson) found between 
select variables. In particular the findings associated with birth weight indicate a 
consistent inverse relationship. From daily matemal smoking, matemal cotinine down to 
cord blood cotinine levels, correlations remain stable, r  =.-.37, p  < .001; r  = -.36, p < 
.OOland r = -.37, p  < .001 respectively. Matemal caffeine consumption on a daily basis 
follows a comparable trend with respect to birth weight, r = -.33, p  < .01, as it correlates 
with matemal smoking, r = .49, p  < .0001; matemal cotinine, r = .38, p  < 0.001 and cord 
blood cotinine, r  = .37, p  < .001. A positive relationship between matemal serum IL-4 
and cord serum IL-4 was also demonstrated, r = .37, p < .004.
Mean daily smoking habits were divided by the mean matemal cotinine 
concentration to produce a matemal cotinine per cigarette value. Parallel calculations 
were performed to produce cord blood cotinine per matemal cigarette and birth weight 
decrease per unit of cord blood cotinine. The following results were generated. Each 
cigarette represented 8.34 ng/ml and 7.3 ng/ml matemal and cord blood cotinine
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respectively. For every 1 ng/ml matemal and cord blood cotinine, birth weight decreased 
by 4.32 and 4.93 g, respectively. In other words, each cigarette smoked produced a 
decrease of 36 g of birth weight as indicated by the matemal and cord blood cotinine 
levels.
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Discussion
No association was observed in this study conducted on 78 Canadian mothers and 
their respective newborns between cord blood IL-4 and matemal smoking or between 
matemal smoking and matemal IL-4. A positive association was found however between 
matemal and cord blood IL-4 levels. No association was observed in IL-4 levels as a 
function of matemal allergic or asthmatic history.
Smoking validation
Validation of smoking habits was verified by serum cotinine measurements. 
Cotinine levels are more relevant to consider than nicotine levels, since cotinine has a 
larger semm half-life (about 18 hours in adults) than nicotine (about 2 hours) and is 
exclusively a product o f in vivo metabolism, thus avoiding contamination problems. 
Smoking data assessed by questionnaire correlated well with both cord and matemal 
semm cotinine levels. Levels observed are comparable to those found in the literature 
(Oryszczyn et al., 1991). Our results demonstrate that cord blood may be used to assess 
matemal smoking in varying degrees as determined by the strong correlation between 
matemal and cord blood cotinine (Figure 4), which supports findings in the literature 
(Jauniaux, Gulbis, Acharya, Thiry, and Rodeck, 1999; Hayde, Bemaschek, Stevenson, 
Knight, Haddow and Widness, 1999). Our results indicate that for every cigarette 
smoked by the mother there is an increase of 8.34 ng/ml and 7.3 ng/ml in matemal and 
cord serum cotinine, respectively. These data can be compared to that in the literature for 
cord semm increase per matemal cigarette at 4.4 ng/ml cotinine (Nafstad, Kongemd, 
Botten, Urdal, Silsand, Pederson, and Jaakkola, 1996). Questionnaires however should
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not be ignored but rather used in conjunction, as cotinine levels reflect short-term 
exposure only, thus not accurately depicting the occasional smoker.
M atem al smoking and perinatal variables
Matemal daily smoking habits and matemal and cord blood cotinine all produced 
a significant decrease in newbom birth weight (Figure 2) when compared against their 
non-smoking counterparts, which is in accordance with much previous research (i.e. Bai, 
Wong, Gyaneshwar and Stewart, 2(XX); Cooke, 1998; Schellscheidt, Jorch, and Menke, 
1998; Comelius, Taylor, and Geva, 1995). Evidence of decreased birth weight in 
mothers who smoked by Haug, Irgens, Skjaerven, Markestad, Baste and Schreuder 
(2000), indicated a 232 g mean reduction in comparison to non-smokers. The current 
study’s data shows a further average reduction in birth weight in the order of 415 g. 
Further analysis of the data in this study revealed that for every 1 ng/ml of cord blood 
cotinine, birth weight decreased by 4.93 g, r =  -.37, p < .001. Low birth weight is a 
significant risk factor in subsequent occurrence of sudden infant death (Haustein, 1999). 
Literature reports (Windham, Hopkins, Fenster and Swan, 2000) of increased incidence 
of pre-term birth (< 245 days) in relation to matemal smoking were not confirmed in this 
study. The mean gestational length in the non-smoking group (n = 42) was 281.6 days 
and 277.72 days in the smoking group (n = 36).
An interesting finding was revealed when comparing matemal cotinine levels to 
corresponding cord blood cotinine. In 19% of the smoking group (7 of 36), cord blood 
cotinine levels exceeded those of the matched matemal levels. Higher cotinine levels 
were reported in fetal serum compared to matemal semm in a study conducted by 
Jauniaux et al. (1999). Reported levels were in a population of mothers and their aborted
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fetuses. This finding in conjunction with our own suggests that the fetus may not be as 
metabolically equipped as the adult mother in dealing with nicotine and cotinine 
degradation both in early pregnancy and at term, another point of interest when 
considering teratogenic effects of nicotine on prenatal development — sustained 
concentration for increased duration.
Counter to common thought was a finding that matemal exercise increased 
significantly with matemal smoking. Considering exercise to be a healthy activity 
requiring assiduousness, one would assume that this would carry over into other ‘healthy 
lifestyles’, notably, non-smoking behaviour. It should be noted that exercise frequency 
was self-reported via questionnaire and may have been inflated to compensate for other 
consciously unhealthy pregnancy practices, such as smoking. If indeed the correlation is 
accurate further research may be warranted to explore this relationship.
Average daily caffeine consumption measured by questionnaire had a strong 
association with matemal smoking indicating, as daily matemal smoking frequency 
increased, caffeine habits followed suit. This finding supports evidence in the literature 
suggesting that caffeine has the ability to potentiate the reinforcing properties of nicotine, 
thus highlighting the importance of environmental factors in shaping and maintaining 
tobacco smoking (Shoaib, Swanner, Yasar, and Goldberg, 1999). It seems logical then to 
request of smoking pregnant mothers who refuse to quit to deny themselves caffeine in 
lieu of abstaining from smoking and perhaps, as research suggests, smoking behaviour 
should decline having less rewarding properties attached to it (not considering the 
behavioural component of addiction).
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Iinterleukin-4 Findings
Interleukin-4’s involvement with the progression to sensitization can be 
considered a critical one. Without its presence, iso-type class switching would fail to 
occur in B-cells, disallowing production of IgE antibody essential for mast cell 
degranulation. In the past IgE has been measured in cord blood in relation to matemal 
smoking only to produce discrepant results. Magnusson (1986) found that in 186 
newbom infants, for which 41 were exposed to matemal smoking, the association 
between matemal smoking and IgE was significant. In opposition are results generated 
from a sample of 325 newboms, 62 of whom had smoking mothers, (Johnson, 
McCullough, Blocki, Strauchman, Jacobsen and Ownby, 1989) no association between 
matemal smoking and cord blood IgE was found.
It was believed that IgE might not be the marker of choice in the matemal 
smoking - fetal sensitization paradigm since the fetus had not yet been directly exposed to 
tobacco smoke and IgE is unable to cross the placental barrier. Among adults, the 
relationship between IgE and smoking has been determined in most studies, however the 
mechanisms involved are unclear. IL-4 levels have been demonstrated to be elevated in 
adult smokers as well (Byron et al., 1994). In their study, the method used to assess 
differences in IL-4 levels was in vitro, via prodding T cells to measure their potential to 
produce cytokines.
An in vivo measure of IL-4 and IFN-y performed in the current study was chosen 
to test the theory of intrauterine priming through placental transfer of cytokine’s 
influence on fetal T cell differentiation (Figure 5). IL-4 was chosen to represent Th2 
expression and IFN-y was selected to represent Thl expression. The cytokines were
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hypothesized to exhibit an inverse relationship. In the smoking group (matemal and cord 
serum) the direction was believed to reveal elevated IL-4 and decreased IFN-y. By 
employing traditional in vitro methods of prodding cells to produce desired cytokines, the 
assessment o f placental transfer of cytokines could not have been performed using the 
design chosen. By measuring cytokine levels, as they exist in vivo in the mother and the 
fetus (cord blood), an accurate depiction of the relationship between cytokine levels 
could be explored. Although the association between matemal smoking and cytokine 
levels was not established according to the hypothesis, a positive correlation was revealed 
between matemal (smoking and non-smoking) IL-4 and cord blood IL-4 (Figure 1), 
suggesting some cytokine activity being shared between mother and fetus. In order to 
confirm whether this finding is a result of matemal cytokine influence on fetal T cell 
differentiation favouring Th2 production, further research is warranted.
The Thl/Th2 paradigm proposed in the literature to represent immune operation 
during pregnancy and that of allergic responding is indeed evidence based. Following 
this model, in addition to adult smoking effects on the immune system, one would deduce 
that the outcome would be upregulated Th2 responding in both matemal and newbom 
units when taking measurements at birth. However, our findings do not bear this 
presumption. Considering our method accurately represents our intent, some other 
mechanism may be at play influencing this model or another variable within our 
population sample requires examination. A recent paper in the literature alludes to the 
proposition of abnormal Th2 responding in atopic positive women and their fetuses. 
Williams, Jones, Miles, Wamer and Wamer (2000), sought to examine IL-13 (possesses 
IL-4 like activity) expression by fetal and neonatal cells and the placenta via cell
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culturing in the presence or absence of PHA. They found that cells stimulated to produce 
IL-13 in samples from atopic positive histories had lower counts compared to those 
without parental atopic histories. The authors concluded that this may be representative 
of an inherent immaturity in the development of T cell-cytokine responses in babies at 
genetic risk for atopy or could be a consequence of downregulation of responses by other 
factors.
It is possible that a subsystem not yet identified in the Th2 arm of the immune 
system is not influenced normally by changes in T hl functioning during pregnancy. 
While the model has Thl responding attenuated during pregnancy, allowing Th2 
functioning to be elevated vis à vis disinhibition, this Th2 subsystem may not follow suit. 
We propose this alternate model following observational data and subsequent literature 
review. Throughout data collection the principal investigator had numerous opportunities 
to speak with the enrolled mothers and fathers on the labour and delivery ward. A 
recurring item of information discussed with the parents with asthmatic histories was 
levels of symptoms before and during the pregnancy. Most often the mother explained 
that asthma inhaler use before pregnancy was considerably increased as compared to 
during her pregnancy. According to evidence of Th2 control during pregnancy and the 
known Th2 supremacy concomitant with asthmatic symptomatology, it seems logical that 
allergic/asthmatic women who become pregnant should be at risk for elevated responding 
and thus increased inhaler use. Several investigators have examined this relationship 
between pregnancy and asthma. Schatz, Harden Forsythe, Chilingar, Hoffman, Sperling 
and Zeiger (1988), found that in 330 matemal asthma associated pregnancies, symptoms 
worsened in 35%, improved in 28%, and was unchanged in 33% of the women. Similar
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findings were found by Stenius-Aamaila, Piirila, and Teramo (1988) in a study conducted 
on 198 asthma associated pregnancies. They found that anti-asthma medication use 
during pregnancy increased in 42%, decreased in 18% and remained unchanged in 40% 
of the women.
Future studies should stratify the allergic disease population, in prenatal origins of 
allergic disease research, into groups representing levels of symptomatology before and 
during pregnancy. These groups would be a function of the level of asthma/allergic 
resistance and proneness to changes in pregnancy associated modifications of immune 
function. It may be that clinically similar allergic disease differ at the level of the 
immune system or genetically and based on these differences offspring are at a greater or 
lesser risk to develop allergic disease. This could be carried out by immuno profiling the 
groups via quantifying Thl/Th2 expression and by using cDNA micro-array technology 
to further classify differences genetically.
In relation to our findings it is possible that the lack of differences in cytokine 
production found as a function of smoking status and allergic/asthmatic history is due to 
factors not considered at the outset of this investigation. It would be interesting to run a 
retrospective pilot study involving re-questioning of participants on their 
allergic/asthmatic symptoms before, during, and after pregnancy and see how this 
classification influences Thl/Th2 cytokine production. If a trend is observed another 
study could be designed with larger numbers in each group.
Conclusion
The association between matemal smoking and the prevalence of allergic disease 
in offspring has long been determined (Arshad & Hide, 1992; Infante-Rivard et al., 1998;
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Jedrychowski & Flak, 1997). The mechanism to account for this relationship has yet to 
be elucidated. This paradigm deserves further research into the biological and molecular 
underpinnings since it’s a model free of important confounds found in similar studies 
relating to the prenatal origins of allergic disease, most notably, consistency of insult. 
When matemal smoking occurs it likely does so daily and in similar amounts. Other 
models suffer from seasonal variation of allergen, high variability in duration of 
exposure, and insufficient biological markers for matemal and fetal levels of the 
suspected insult. For these reasons the matemal smoking paradigm is fitting to provide a 
base from which to develop. To isolate possible targets in the chain of events leading to 
sensitization that is being exploited in the fetus during gestation, points of intervention 
could be explored and the birth of prenatal management o f allergic disease may not be far 
to follow.
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Figure 1. Relationship between matemal serum IL-4 (pg/ml) and umbilical cord serum 
IL-4 (pg/ml).
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Fig. 2. Daily matemal smoking habits, matemal serum cotinine and cord serum cotinine 
according to newborn birth weight.









r = .70, fi < .0001
-10
-100 100 200 3000
Maternal cotinlne (ng/m!)
Fig. 3. Relationship between matemal daily smoking habits and corresponding matemal 
blood cotinine.
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Figure 4 . Relationship between maternal blood cotinine and newborn cord blood 
cotinine.
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Figure 5. Intrauterine priming model. Matemal smoking generates increased production 
of Th2 type cytokines while suppressing expression of T h l type cytokines. Cyokines 
cross the placental barrier priming ThO cells to differentiate in the Th2 direction 
beginning at 22 weeks gestation. Sustained Th2 proliferation and Th2 cytokine 
expression in the fetus driven by cytokines derived from matemal circulation create an 
immuno environment favouring IgE sensitization. Posmatal exposure to ETS is met with 
vigorous responding in the newbom encouraging development of allergic disease.















































Sex ratio M/F 38/40 22/20 16/20
Birth weight (grains), 
mean





APGAR at 1 min., mean 7.24 2-9 1.68 7.23 2-9 1.75 7.25 3-9 1.61
APGAR at 5 min., mean 8.67 3-10 0.94 8.62 3-10 1.17 8.72 7-9 0.57
Cord blood cotinine 
(ng/ml), mean
39.06 0-250 59.57 0.38 0-8 1.72 84.19 8-250 62.55
Cord blood IL-4 
(pg/mt), mean
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Meconium stain, (%) 9 7.1 111



























































N 78 42 36
Age (years) 27.6 18-44 4.99 28.67 26.36 18-36 4.64
Asthma (%) 16.7 21.4 111
Allergy (%) 29.5 35.7 22.2
Smoking (cigs/day). 5.32 0-30 7.35 0 0 0 11.53 4-30 6.73
mean
Cotinine (ng/ml), mean 44.49 0-250 69.01 0.19 0-8 1.23 96.17 8-250 73.31
IL-4 (pg/ml), mean 0.111 0-1.32 0.23 0.104 0-0.74 0.20 0.117 0-1.32 0.26
20 minutes of exercise 3 0-12 2.38 2.21 0-7 1.62 3.92 0-12 2.79
per week, mean
Ethnic origin, (%)
Caucasian 92.3 92.9 91.7
First Nation 6.4 4.8 8.3
Latin 1.3 2.4 0
Caffeine products per 2.46 0-10 2.04 1.52 0-6 1.38 3.56 O-IO 2.14
*These cases have diagnosed gestational diabetes
46
Table 2.
Relationships among chosen variables
Variables r Variables r
smoking / M. cotinine .70^ C. cotinine /  caffeine 3 f
smoking / C. cotinine .66^ caffeine /  exercise .40^
M. cotinine / C. cotinine .87^ Tcaffeine / 4-birth weight -.33**
Tsmoking / -Ibirth weight -.37^ smoking / exercise .41^
TM. cotinine / 4-birth weight -.36^ APGAR/APGAR 
(1 min) (5 min)
.62^
TC. cotinine / 4-birth weight -.37^ M. age / parity .24*
smoking / caffeine .49^ gestational length /  birth weight .36^
M. cotinine / caffeine .38^ ETS /  M. cotinine .24*
M. IL-4 / C. IL-4 31"




M - matemal, C - cord blood 
T,4r - description of correlation 
ETS - environmental tobacco smoke
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Dear Participant,
Hello, my name is James Koprich and I invite you to be a participant in a very exciting study. I am a 
graduate student attending Lakehead University, completing a research project as part of my Master’s 
degree. The basis of this research is to explore the possibility that during pregnancy the fetus may 
develop the potential to become allergic or asthmatic. This study will attempt to better understand 
immune system functioning during pregnancy in hopes of developing an intervention to reduce childhood 
allergic disorders.
First you will be asked to fill out a confidential questionnaire (attached). It is important that you read the 
instructions carefully and be completely honest when answering. Completed questionnaires will provide 
me with information about you and your pregnancy. I  will attempt to determine how items on the 
questionnaire influence immune functioning.
As part of routine delivery, blood samples from you and the umbilical cord are collected for hospital lab 
analysis. In order to investigate the immune system I require your permission to examine these already 
collected blood samples. I will be looking at parts of the immune system related to asthma and allergy 
development. By participating in this research absolutely no part of the birthing routine is altered. All 
information gathered will remain CONFIDENTIAL and will be stored at Lakehead University for a 
period of seven years, after which time will be destroyed or remain confidential in my hands.
Community participation in any research is extremely valuable. It is an opportunity to be a part of 
science and provide information that may lead to improving quality o f life. By volunteering consent to 
participate in the research at hand, you will be credited with improving the quality of our children’s lives.
Ethics committees from Lakehead University and Thunder Bay Regional Hospital have approved this 
research project. Feel free to call James Koprich (344-9010) if you have any questions or concerns. If 
you decide at any time to withdrawal from this study your medical care will not be affected. By 
consenting below, you have agreed to all of the requirements outlined above and volunteer to participate 
in this research. This study is supported by the Asthma Society of Canada.
Date ------------------ Name
Participant signature
James B. Koprich, HBSc 
Principal Investigator
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Code M-
Pregnancy Lifestyles Questionnaire
Many thanks for participating in Üiis research. Your contribution will be 
absolutely confidential and more importantly will facilitate our knowledge of
pregnancy and science!
Instructions: Please provide answers to all questions which relate to personal lifestyles during vour
pregnancy. When a number is required please provide a single number, not a range (i.e. lo, not 5-10) 
in the boxes. This number can represent an average. Other questions simply require a V ’ in the 
circles.
Age Ethnic Origin: A sian^^ A fricanQ  C aucasian^  First Nations^^) East Indian Q  
Latin Other -------------------------
1- On average, how many caffeine products (coffee, tea, cola, etc.) do you consume daily? 
(i.e. 2 Colas + 3 coffees +1  tea = 6 caffeine products)
2 . How often, in one week, do you engage in at least 20 minutes of activity intended to 
be exercise?
3 . Have you participated in any prenatal classes? (i.e. Lamaze) Yes No O
4 . How many cigarettes, on average, do you smoke in one day?
(smoking history will be evaluated additionally by chemically analyzing the blood samples)
1 pack of 25 (2) Less than a pack (state number of cigs)
2 packs of 25 Q  Less than 2 packs (state number of cigs]j^
Other □
Are you exposed to second hand smoke? Y esQ  No If Yes, where? At home Q  At work Q
5 . Do you have a history of allergies? Y e ^ ^  No Q  Asthma? Yes Q  No Q
Does the father have allergies? Y e s (^  No Q  Asthma? Yes No
Have your allergies been diagnosed by a doctor? Ye(2) No^^) Asthma? Y es^^ No Q
Are you taking medication for your allergies and/or a s th m a? Y e ^ ^  No
6 . Have you been taking any vitamins or supplements during your pregnancy? Y ^ ^  N ^ ^
Thank you kindly, and best wishes to you and your baby
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If you wish, please write in your name and address on the label attached to this sheet and 
a copy of the results and conclusions will be mailed to you.
Thank you,
James Koprich
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